We’re proud to highlight that Tyrolpath, the largest private pathology lab in western Austria, is the first lab in Austria to adopt MSK-IMPACT®-Flex powered with SOPHiA DDM™, marking a major milestone for precision oncology in the country. With approximately 45,000 new cancer diagnoses reported each year, there is a strong need for comprehensive genomic profiling (CGP) to identify […]
DNASTAR is pleased to announce a new distribution partnership with ONEOMICS PRIVATE LIMITED, now serving as the authorized representative for Lasergene® bioinformatics software in South India. Through this collaboration, researchers across the region will gain expanded access to the full range of DNASTAR tools for genomics, molecular biology, and structural biology, supported by dedicated local […]
Proprietary agentic AI model transforms genomic and real-world data into actionable insights across the full drug lifecycle Enables faster development of breakthrough therapies, including tumor-agnostic cancer treatments, through a 360-degree view of the precision medicine landscape Empowers scientific researchers across the life sciences and healthcare continuum to perform large-scale data analysis for the advancement of […]
BOSTON and SAN DIEGO — SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, and Element Biosciences, Inc., a biology company transforming the pace and accessibility of scientific discovery, today announced at the Association for Molecular Pathology (AMP) Annual Meeting a partnership that unites sequencing and AI analytics to streamline genomic workflows and accelerate the research supporting […]
BOSTON — Complete Genomics, a leading innovator in genomic sequencing, today announced a collaboration with SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, to launch and co-market MSK-ACCESS® and MSK-IMPACT® powered with SOPHiA DDM™ on Complete Genomics’ DNBSEQ-T1+ sequencing platform. The companies aim to broaden access to precision oncology testing by offering the best-in-class liquid biopsy […]
mzio GmbH and Bright Giant GmbH announce a new integration between mzmine and SIRIUS. This collaboration enables researchers to launch SIRIUS analysis directly from mzmine feature tables, automating result handling and eliminating the need for manual data transfer to streamline small molecule discovery workflows. Bremen, Germany and Jena, Germany – mzio GmbH, the company behind the […]
Redefining Scalability, Automation, and Clinical Yield in Genomic Interpretation BOZEMAN, Mont. — Golden Helix, Inc. announced the release of VarSeq 3 and VSWarehouse 3, the company’s next-generation platform for secondary and tertiary genomic analysis. Building on more than a decade of trusted innovation, the clinical utility of VarSeq 3 has been expanded through industry partnerships and customer collaborations. […]
Latest release accelerates hit-to-candidate progression by keeping teams aligned, eliminating inefficiencies and enabling better prioritisation decisions CAMBRIDGE, UK – Optibrium, a leading developer of software and AI solutions for molecular design, today announced the release of StarDrop 8, the most significant update to its comprehensive discovery platform in its 20-year history. StarDrop 8 integrates real-time collaboration into […]
Founded by deep scientific experts across biomedical engineering, stem cell biology and organoid systems Funding round led by First Star Ventures CHAPEL HILL, N.C. — iOrganBio today announced its launch from stealth with $2 million in funding to transform how human cells are made. The round was led by First Star Ventures along with institutional […]
SOPHiA GENETICS Launches AI-Powered Digital Twins to Enhance Intelligent Decision-Making in Oncology
BOSTON and ROLLE, Switzerland — SOPHiA GENETICS (Nasdaq: SOPH), a leader in AI-driven precision medicine, today announced the launch of SOPHiA DDM™ Digital Twins, a breakthrough research technology that creates dynamic, virtual representations of individual patients to simulate potential outcomes and help oncologists make better treatment decisions. SOPHiA DDM™ Digital Twins uses each patient’s unique […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
